Conclusions When TCA is managed as above, there is a high prevalence of recurrent symptoms in the following 3 months.
Symptoms were assumed to be due to recurrent corneal erosion if they were described as frequent and significant pain, grittiness, photophobia or watering of the injured eye only. 6
Patients may suffer repeated attacks of macroform RCE, and various treatments have been assessed as secondary prevention in established RCE syndrome?-lO
One of the simpler treatments advocated to prevent further attacks is the nightly use of a topical eye ointment.11,12 Our study set out to assess whether nightly topical ointment would be useful as a primary treatment after TCA. We hoped that this treatment would prevent the development of RCE following TCA.
The study set out to answer the following questions: Patients were followed up 3 months after the initial injury by telephone, using a symptom-based questionnaire. Symptoms were assumed to be due to the initial injury if they were described as frequent and significant pain, grittiness, photophobia or watering of the injured eye only.6 Recurrent symptoms were graded as: (i) none or minimal, (ii) mild, (iii) moderate (difficulty with some daily activities, or sought further advice from a health professional) and (iv) severe (macroform recurrent erosion confirmed on examination). Case-notes were reviewed at 2 years. Results were analysed statistically using chi-squared test. The study is continuing, with further telephone follow-up to take place at 3 years.
Results
Seventy-four patients completed the 3-month follow-up questionnaire ( Table 1) . In 42 cases, the injury was caused by a fingernail. At 3 months there was a high prevalence of symptoms suggestive of RCE. A total of 21 patients (28%) reported frequent and significant pain, grittiness, photophobia or watering of the injured eye only.
We found no significant difference in overall symptom prevalence between 'fingernail' and 'non fingernail' injuries which had been managed with our standard regimen (chi-squared test: p = 0.54). Severity of symptoms was broadly similar in these two groups (see Table 1 ). For injuries caused by a fingernail, the use of additional nightly ointment was associated with a higher prevalence of symptoms at 3 months (significant to chi squared test, p = 0.016). By 2 years, two patients, both with 'fingernail' injuries, had presented to us with macroform RCE: the first was 3 months after TCA treated with the 'standard' regimen, the other 7 months after TCA treated with additional nightly ointment.
Discussion
TCA in otherwise healthy eyes is associated with a high prevalence (28%) of current symptoms in the first 3 months. Nine patients in our study (12%) reported symptoms which interfered with some daily activities, or led them to seek advice from Eye Casualty, general practitioner or pharmacist. The reasons why these patients did not all re-attend Eye Casualty were not explored in our questionnaire, but we suspect that this was due to a combination of factors, including the transient nature of the symptoms.
We found the incidence of the disabling 'macroform' RCE to be of the same order as other studies. This is an early report from a continuing study. The unexpected results challenge the preconceptions that patients are generally symptom-free within days of TCA, and that nightly ointment is of symptomatic benefit. Our results also demonstrate that any future evaluation of treatment for TCA should include a follow-up of patient symptoms.
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